The Relationship Between Vitamin D and the Development and Treatment of Attention-Deficit Hyperactivity Disorder: An Overview of Systematic Reviews
Kitaneh R, Jalilian-Khave L, Ysrayl B, Borelli A, Funaro M, Potenza M, Angarita G. The Relationship Between Vitamin D and the Development and Treatment of Attention-Deficit Hyperactivity Disorder: An Overview of Systematic Reviews. Current Behavioral Neuroscience Reports 2024, 11: 164-181. DOI: 10.1007/s40473-024-00278-7.Peer-Reviewed Original ResearchAttention-deficit/hyperactivity disorderAttention-deficit/hyperactivity disorder symptomsTreatment of attention-deficit hyperactivity disorderSeverity of ADHD symptomsAttention-deficit hyperactivity disorderManagement of attention-deficit/hyperactivity disorderOutcomes of attention-deficit/hyperactivity disorderOverview of systematic reviewsADHD symptomsSerum vitamin D levelsHyperactivity disorderInclusion criteriaMeta-analysesVitamin D levelsBrain regionsMaternal serum vitamin D levelsPrenatal vitamin D levelsAssociated with improvementsNeurotransmitter regulationRisk of offspringVitamin D supplementationD levelsWell-powered randomized clinical trialsSystematic literature searchSummaryThe literatureAntipsychotic agents in anxiety disorders: An umbrella review
Garakani A, Buono F, Salehi M, Funaro M, Klimowicz A, Sharma H, Faria C, Larkin K, Freire R. Antipsychotic agents in anxiety disorders: An umbrella review. Acta Psychiatrica Scandinavica 2024, 149: 295-312. PMID: 38382649, DOI: 10.1111/acps.13669.Peer-Reviewed Original ResearchSecond-generation antipsychoticsFirst-generation antipsychoticsGeneralized anxiety disorderStudies of antipsychoticsAnxiety disordersAntipsychotic agentsEfficacy of first-generation antipsychoticsTreatment of anxiety disordersEfficacy of antipsychotic agentsMeta-analysesAntidepressant treatmentNonantipsychotic medicationsAntipsychoticsFirst-line treatmentAnxietyComparing monotherapyUmbrella reviewDisordersQuetiapineSystematic reviewSide effectsAMSTAR-2Off-labelAPA PsycInfoCINAHL Complete